From January 1, 2022 to March 31, 2022, the company has repurchased 1,100,374 shares, representing 0.18% for $127.61 million. With this, the company has completed the repurchase of 8,667,297 shares, representing 1.39% for $1,000 million under the buyback announced on May 8, 2019.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
88.61 USD | +0.98% | -1.60% | +16.21% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 17 | Baird Adjusts Edwards Lifesciences Price Target to $102 From $100 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.21% | 52.82B | |
+8.78% | 219B | |
+8.24% | 187B | |
+11.16% | 134B | |
+26.12% | 101B | |
+0.30% | 62.27B | |
-1.63% | 47.49B | |
-1.11% | 40.79B | |
+12.16% | 39.35B | |
+6.84% | 27.06B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on May 8, 2019.